← Evidence map

ArticleOncotarget2016

MiR-449a promotes breast cancer progression by targeting CRIP2.

Wei Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

38 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 26934316